Medicinal uses of Redpalm

Redpalm drug is now known quite popularly with the main effect of preventing blood clots. The following article shares the most useful usage and notes when using Redpalm.

Redpalm is a cardiovascular drug, prepared in the form of film-coated tablets, packaged in a box of 3 blisters x 10 tablets with the main ingredient is Clopidogrel 75mg.

Redpalm drug has the ability to prevent the adhesion of platelets, prevent the formation of blood clots, and help the circulatory system to circulate without obstruction causing harm to the body. Therefore, Redpalm is indicated for use in:
Primary prevention of thromboembolic disorders such as myocardial infarction, stroke, peripheral artery disease. Control, secondary prevention in patients with a history or recent history of myocardial infarction, stroke, or peripheral arterial disease identified.

3.1. Dosage Redpalm is used as follows:
Redpalm is used as a single dose of 1 tablet (75mg)/day, taken during or after meals about 10-15 minutes. For acute coronary syndrome (main manifestation is unstable angina, non-Q-wave myocardial infarction), the starting dose is 300mg (4 Redpalm tablets) and is used only once. The daily maintenance dose is 75mg/day. However, depending on the condition or age of the patient, the dose may be changed differently. Patients need to strictly adhere to the treatment regimen of the doctor and not arbitrarily change the dose.
3.2. How to take Redpalm is taken orally. Because the drug has a prolonged release, it is recommended that the patient should not break or crush the drug to drink.
Redpalm can be used with or without food every day.

When forgetting a dose of Redpalm, the patient takes it as soon as he remembers. If it is almost time for the next dose, skip the missed dose and take the next dose on schedule. Do not arbitrarily make up the dose the next day because it will cause unwanted side effects.
When clopidogrel overdose leads to prolongation of bleeding time causing complications of bleeding. Manifestations of acute toxicity are vomiting, fatigue, dyspnea, gastrointestinal bleeding. So, when you accidentally overdose on Redpalm, the patient should stop taking the medicine immediately and notify the doctor, in case of an emergency, take the patient to the nearest medical facility and bring all the prescriptions and the medications that the patient has been using for the doctor to diagnose and provide timely treatment.

Do not use Redpalm in the following cases:
Patients with hypersensitivity to Clopidogrel or to any of its ingredients. Patients with bleeding diseases such as gastrointestinal ulcers, cerebral hemorrhage. Patients with severe liver failure, severe kidney failure. Because there are no reports on the safety of the drug, it is not recommended to use the drug in pregnant and lactating women.

Redpalm may interact with some of the following drugs:
Aspirin : Care should be taken when combining these two drugs as there have been reports of a pharmacodynamic interaction between Clopidogrel and Aspirin that increases the risk of bleeding. However, they can be combined together for periods of up to 1 year. Heparin, Warfarin : Care should be taken when combining Clopidogrel with Heparin and Warfarin because of the risk of bleeding. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Caution should be exercised when clopidogrel is co-administered with this class of drugs because, according to clinical studies, there may be an increased risk of potential gastrointestinal bleeding. Drugs metabolised by the Cytochrome P450 system: Due to high concentrations in In vitro experiments, Clopidogrel inhibits Cytochrome P450 (2C9). Therefore, the drug can affect the metabolism of the following substances: Tamoxifen, Phenytoin, Tolbutamide, Warfarin, Torsemid, Fluvastatin, but there are no data on the severity of these interactions. Care should be taken when combining clopidogrel and these drugs. Other Combination Treatments: When used in combination with drugs that inhibit CYP2C19 enzyme activity there is a risk of decreased concentrations of the active metabolite Clopidogrel. Therefore, caution should be taken when co-administering with drugs that inhibit the CYP2C19 enzzyme (Omeprazole, Esomeprazole, Fluvoxamine, Fluoxetine, Moclobemide, Voriconazole, Fluconazole, Ticlopidine, Ciprofloxacin, Cimetidine, Carbamazepine, Oxcarbazepine and Chloramphenico) in rare cases. encountered interactions between metabolites of the drug with drugs such as antifungal drugs, Bupropion drugs. Avoid using stimulants such as alcohol, tobacco, carbonated... during the use of Redpalm because it can reduce the effect of the drug.

When using Redpalm medicine, there may be some unwanted effects such as:
Skin allergies: Appears itchy rash or red rash. Digestive system disorders: Diarrhea, abdominal pain, flatulence, dyspepsia, vomiting and nausea. Rarely, it can cause gastrointestinal bleeding, stomach ulcers. Rare cases can be: Chest tightness, nosebleeds. Rarely, some side effects such as: Decrease or loss of neutrophils, agranulocytosis, anemia, nephritic syndrome, decreased taste, acute arthritis, ocular and intracranial hemorrhage. If the patient shows any unusual symptoms of the body, it is necessary to immediately notify the doctor or pharmacist for advice and solutions. In case of serious condition, it is necessary to take the patient to the nearest medical facility for timely emergency treatment.

There are some following notes when using Redpalm, patients should note:
Be careful when using the drug in patients who have been and are being treated for liver and kidney diseases. Use caution when using the drug for patients with bleeding due to trauma, surgery, other diseases. It is recommended that Redpalm be discontinued prior to surgery. It is recommended that patients with recent history of acute heart failure not initiate therapy with clopidogrel. Store the medicine in cool, dry conditions and avoid direct sunlight. To medicines out of reach of children.